about
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosisSelective intestinal decontamination for the prevention of early bacterial infections after liver transplantationPentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipientsLung transplantation: overall approach regarding its major aspectsEarly respiratory complications after liver transplantationCMV: Prevention, Diagnosis and TherapyNon-viral infections in children after renal transplantationAn important role for autoimmunity in the immunopathogenesis of chronic allograft rejectionMucormycosis in a renal transplant recipient: case report and comprehensive review of literatureBacterial infection after liver transplantationCell therapy to induce allograft tolerance: time to switch to plan B?Donor cancer transmission in kidney transplantation: a systematic reviewInfections after orthotopic liver transplantationProlonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferretsSoluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulationReconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesThe Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ TransplantationPathology of infectious diseases: what does the future hold?Infection in Organ Transplantation.Clinical features of H1N1 2009 infection in critically ill immunocompromised patients.Donor risk index predicts graft failure reliably but not post-transplant infections.Hospital epidemiology and infection control in acute-care settings.Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipientsSpontaneous restoration of transplantation tolerance after acute rejection.Tacrolimus-associated thrombotic microangiopathy in a lung transplant recipientHematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Predictors of mortality in solid-organ transplant recipients with infections caused by Acinetobacter baumannii.Epstein-Barr virus and cytomegalovirus infections and their clinical relevance in Egyptian leukemic pediatric patients.Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.Pros and cons of liver transplantation in human immunodeficiency virus infected recipients.Voriconazole pharmacokinetics in liver transplant recipients.Strategies to modulate immune responses: a new frontier for gene therapyOutcome in Pancreas Grafts After BK Virus Viremia in Simultaneous Pancreas-Kidney Transplants: A Single-Center Case Report.Xenotransplantation - A special case of One HealthCD8⁺ T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis.Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosisImpact of maintenance immunosuppressive regimens--balance between graft protective suppression of immune functions and a near physiological immune response.Emerging viral infections of the central nervous system: part 1.A Systematic Review and Meta-analysis of Prophylactic versus Pre-emptive Strategies for Preventing Cytomegalovirus Infection in Renal Transplant Recipients.Primary care of the renal transplant patient.
P2860
Q24198071-7E4A473E-140D-4C7C-81D4-626785EE42F4Q26741221-34A6D331-AFAE-432B-AA4A-C5A05B30DF4FQ26751428-4B83B2BB-2955-4AC2-9F89-6E2384609721Q26770911-22695188-23E1-4265-9FFC-5DFBE886DEA4Q26823081-F9F72DF6-FBF5-4F74-9EFD-91C32966E646Q26824869-FEA36D8D-6ACF-4425-BB15-3C218213E119Q26825208-0B90CF24-ED31-4C43-9822-C6E11BF2D237Q26827623-298DB0A8-ADD5-47E2-8C66-71862A0E5FD5Q26860727-51678A7B-8BCB-4804-B11D-F7D93DE78BEAQ26991438-9E680E26-AACC-4F85-A13C-59273379FC4DQ27013040-496E416B-D4F4-4F8C-AF36-6D8BBFC9F314Q27015945-2B3D69FF-568F-41FB-8343-1491A44D6871Q27023182-B5823BE4-3F09-48D4-893B-672D432A4AEFQ27334946-4B22B64F-2630-4152-A271-AA72448F0F9DQ28080245-513A55FE-20AF-4E65-BED5-D38CB40C8BF7Q28080994-CAB04F5C-9A59-4837-9D6A-D7879CAD9593Q28085440-369E2F8B-A318-49CE-BCFB-E6053DE12D19Q30235969-4CAA2E8D-7F54-4623-AB8E-2B540FA71690Q30238810-4D1CE8D3-DA33-41CF-88A9-C71AF1BCC5DFQ30388083-E1ECE816-F444-4967-BD40-9491FE0029A4Q30409680-75F38462-4552-4D2B-8EAC-E5E4430A50A4Q30429049-81411FFE-F988-4556-8220-BF6A0AE887CDQ30433281-B8E53039-66BC-404C-BA4D-51D5A2C44D28Q30657418-CB3A8E10-9E6F-4409-BA98-52AAA2D15CB5Q33405793-32451509-1155-467E-BB4A-297702C50EEBQ33424902-EB552CFF-1FF2-4BE6-8BD5-A32CB5CA1AE9Q33425665-62AEC4CD-5B02-42F0-A0C1-38CC7878E21DQ33439883-B887AB3A-74A8-4DC9-A437-A974378E023EQ33522300-6B9DB4D1-4308-4CCD-B5F3-2F14A8809C36Q33594879-EDCB13F2-B784-498D-834A-C574230D7231Q33613685-B38AD645-965C-4577-926A-A401F17F91A5Q33713999-4089E068-350A-4347-8FD5-B3226EB7224CQ33719816-9833151E-6B3C-4710-8659-9DC1221ACCF0Q33753481-2B0F32E6-F9B4-4968-B371-360193C7C625Q33754548-6771E28D-A283-4F7F-BFF7-5287075C7D15Q33802186-55EC0BB3-DA1B-4281-9FA6-1F66FFF6BD62Q33845320-E0CECA61-3ED6-4018-9001-ACAB7B077C70Q33866041-EB90A411-1A73-4BD3-B2CC-5AA34F6A71E2Q33871850-FD74257C-D0B8-49C7-8F92-8BF6369A9031Q33898744-E3BA2D25-BC18-4FB6-AF46-455818286F70
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Infection in solid-organ transplant recipients.
@en
Infection in solid-organ transplant recipients.
@nl
type
label
Infection in solid-organ transplant recipients.
@en
Infection in solid-organ transplant recipients.
@nl
prefLabel
Infection in solid-organ transplant recipients.
@en
Infection in solid-organ transplant recipients.
@nl
P356
P1476
Infection in solid-organ transplant recipients.
@en
P2093
Jay A Fishman
P304
P356
10.1056/NEJMRA064928
P407
P577
2007-12-01T00:00:00Z